AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy
Clinical trial NCT07118735 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07118735
- Sponsor
- National Cheng-Kung University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-20
- Primary completion
- 2027-12-31
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.